Access

Access

Genomics should be available to the many, not the few. It has the power to save lives and vastly improve the human condition. As the leader in genomics, we have the obligation to drive down the cost of sequencing, expand access to diagnostics technology, and increase the diversity of genomics data to realize health equity for billions of people around the world.

Content from this campaign

Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children
SAN DIEGO, April 25, 2022 /3BL Media/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced an agreement with Germany's Hannover Medical School (Medizinische Hochschule Hannover (MHH)) to implement the use of whole-genome sequencing (WGS) in critically ill children suspected of having a genetic or rare disease. The project, led by the...
Apr 27, 2022 9:00 AM ET
Baby Fitz's Life-Saving Diagnosis Through Whole-Genome Sequencing
In June 2019, Christina and Daniel Kettler were barely home from the hospital with their newborn son when they received an urgent phone call. They needed to rush back immediately: A routine screening, called the heel stick test, had revealed that Fitz, their firstborn baby, had Severe Combined Immunodeficiency (SCID). SCID is a rare condition also known as “bubble boy disease.” “To be...
Apr 25, 2022 2:40 PM ET
Illumina Expands Access to Genomics in Latin America Through New State-of-the-Art Solution Center
SAN DIEGO, April 13, 2022 /3BL Media/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of its new state-of-the-art Solution Center in São Paulo, Brazil. The choice to bring the facility to Brazil reflects an increasing demand for and interest in clinical genomics, as well as Illumina's longstanding commitment to...
Apr 13, 2022 9:00 AM ET
For Kidney Transplant Recipients, a More Accurate and Tailored Care Plan
For years, clinicians have used genomics to better inform treatment and personalize therapies. Now, Verici Dx, an immunodiagnostics company based in Tennessee (US), wants to turn that personalized medicine lens to a different field: kidney transplants. Tens of thousands of patients receive kidney transplants every...
Apr 5, 2022 9:00 AM ET
Join Illumina on World Tuberculosis Day to Raise Awareness and Keep the Fight Up to Eradicate TB
Which infectious disease kills more people in the world than any other? It mutates, mostly impacts your lungs, very contagious in a close household setting, can be asymptomatic and hard to eradicate. Did you want to say COVID? Actually, its Tuberculosis (TB) and today marks the day 140 years ago that Dr. Robert Koch announced the discovery of Mycobacterium tuberculosis, the bacterium...
Mar 24, 2022 4:15 PM ET

Pages

  • 3
  • 4
  • 5
  • 6